ATLANTA, Aug. 22, 2024 (GLOBE NEWSWIRE) — A shareholder class action lawsuit has been filed against Orthofix Medical Inc. (“Orthofix” or “the Company”) (NASDAQ: OFIX). The lawsuit alleges that Orthofix’s management team was engaged in “repeated inappropriate and offensive conduct that violated multiple code of conduct requirements,” which was “inconsistent with the Company’s values and culture.” When the truth about the Company’s management team was revealed, the price of Orthofix common stock suffered sharp declines.
If you bought shares of Orthofix between October 11, 2022, and September 12, 2023, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/orthofix-medical/ to learn more.
The deadline to ask the court to be appointed lead plaintiff in the case is October 21, 2024.
Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, and 2023, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.
CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
cholzer@holzerlaw.com
- Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement - May 15, 2025
- Reading International Reports First Quarter 2025 Results - May 15, 2025
- Columbus Circle Capital Corp I Announces Pricing of Upsized $220,000,000 Initial Public Offering - May 15, 2025
